Nathan Shock Centers Coordinating Center (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-25-013 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity Announcement (NOFO) invites applications to develop and maintain a (NSC3). The goal of the NSC3 is to provide logistical and organization support of the NSC. Applicants should be familiar with Nathan Shock Centers (NSC) activities, but they do not need to be part of an NSC. Major activities of the proposed NSC3 will include improving visibility of the NSC nationally and internationally, improving collaboration and coordination among NSC, enhancing NSC training activities, facilitating the sharing of resource...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 18, 2024 Category: Research Source Type: funding

Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-25-012 from the NIH Guide for Grants and Contracts. This NOFO invites applications for the Nathan Shock Centers of Excellence in Basic Biology of Aging (NSC). These Center grants will provide funding for leadership, training, research, and outreach activities that will increase and disseminate scientific knowledge in areas supported by the NIA's Division of Aging Biology. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 18, 2024 Category: Research Source Type: funding

Lethal Means Safety Suicide Prevention Research in Healthcare and Community Settings (R34 Clinical Trial Required)
Funding Opportunity RFA-MH-25-120 from the NIH Guide for Grants and Contracts. NIMH seeks applications to evaluate the preliminary effectiveness of therapeutic and service delivery interventions that utilize lethal means safety strategies to reduce suicide risk in healthcare and community settings. Behavioral health clinics that incorporate lethal means counseling into their programming have been associated with significant reductions in suicide attempts and death. Yet, the field is lacking strong evidence on the effectiveness of these strategies tested in healthcare and community settings. Pilot effectiveness research ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 18, 2024 Category: Research Source Type: funding

Notice Announcing the Systems Biology Data Platform Leveraging the Accelerating Medicines Partnership (OT2)
Notice NOT-RM-24-008 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 18, 2024 Category: Research Source Type: funding

Notice of Information: NICHD to issue a Research Opportunity Announcement to support Advancing Cures and Therapies and ending ENDOmetriosis diagnostic delays - ACT ENDO (OTA Clinical Trial Optional)
Notice NOT-HD-24-016 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 18, 2024 Category: Research Source Type: funding

Notice Announcing Publication of Development and Application of Ophthalmic Imaging Technologies to Advance Our Understanding of Systemic Diseases (OT2) Research Opportunity Announcement
Notice NOT-RM-24-007 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 18, 2024 Category: Research Source Type: funding

Mechanisms of Cognitive Fluctuations in ADRD Populations (R01 - Clinical Trial Optional)
Funding Opportunity RFA-NS-25-014 from the NIH Guide for Grants and Contracts. "Fluctuating cognition can occur in many types of dementia and is a core clinical feature of Dementia with Lewy Bodies. Cognitive fluctuations can last from seconds to days, are unpredictable (e.g., do not just occur in the evenings, as with sun-downing), and are associated with poor daily functioning for the patient. A number of small studies have suggested that cognitive fluctuations in subjects with dementia may be related to epileptiform discharges and impaired oscillatory activity on EEG, but it is not clear that these are the only facto...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 18, 2024 Category: Research Source Type: funding

Notice of Special Interest (NOSI): Administrative Supplements for Assessing and Enhancing Survivorship Care
Notice NOT-CA-24-035 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2024 Category: Research Source Type: funding

Notice of Intent to Publish a Funding Opportunity Announcement for The Road to Prevention of Stillbirth (UM2 Clinical Trial Not Allowed)
Notice NOT-HD-24-010 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2024 Category: Research Source Type: funding

Notice of Intent to Publish a Funding Opportunity Announcement for The Road to Prevention of Stillbirth (UG1 Clinical Trial Optional)
Notice NOT-HD-24-009 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2024 Category: Research Source Type: funding

Notice of Pre-Application Webinar for RFA-AG-25-005: Open Measurement Coordinating Network for Non-Pharmacological Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Primary Prevention Trials (U24 Clinical Trial Not Allowed)
Notice NOT-AG-24-007 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2024 Category: Research Source Type: funding

Notice of Intent to Publish a Funding Opportunity Announcement for Research to Advance the Science of Primary Care (R01)
Notice NOT-HS-24-010 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2024 Category: Research Source Type: funding

Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-25-005 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to support research towards identifying and characterizing neuroimmune networks, communication pathways, and targets that reside within neuroimmune axes, in the context of HIV and substance use. This NOFO will also support research on the discovery of novel modulatory probes/tools that can advance our knowledge of the regulatory mechanisms by which neuroimmune interactions contribute to HIV and substance use disorder comorbidity. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 14, 2024 Category: Research Source Type: funding

Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-25-004 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to support research towards identifying and characterizing neuroimmune networks, communication pathways, and targets that reside within neuroimmune axes, in the context of HIV and substance use. This NOFO will also support research on the discovery of novel modulatory probes/tools that can advance our understanding of the regulatory mechanisms by which neuroimmune interactions contribute to HIV and substance use disorder comorbidity. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 14, 2024 Category: Research Source Type: funding

Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)
Funding Opportunity RFA-OD-24-014 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support collaborative, transdisciplinary, translational research projects which advance exceptionally promising, chemically complex botanical and other natural products relevant to dietary supplements towards highly informative clinical trials of their effects on quantitative, objective measures of human resilience. Dynamic, synergistic interactions among the range of experts required to ensure rigor in all aspects of this research will be supported by a multi-PD/PI team collabora...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 14, 2024 Category: Research Source Type: funding